Concepedia

Markus Reschke

MR

Statistics

Publications

25

Citations

3K

H-Index

19

Active since

2003

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Research Institute of Molecular Pathology

Max Planck Institute of Biochemistry

Brigham and Women's Hospital

Markus Reschke is an author at Beth Israel Deaconess Medical Center specializing in life sciences, molecular oncology, and medicine.

Publications per year

2003–2024

25

Publications

25

Impaired Long-Term Memory and NR2A-Type NMDA Receptor-Dependent Synaptic Plasticity in Mice Lacking c-Fos in the CNS

Alexander Fleischmann, Øivind Hvalby, Vidar R. Jensen et al. · Journal of Neuroscience · 2003 · 387 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo

Florian A. Karreth, Markus Reschke, Anna Ruocco et al. · Cell · 2015 · 368 citations · Full text

Medicine, Genetics, Oncology +11

Axl and Growth Arrest–Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

Markus Hutterer, Pjotr Knyazev, Ariane Abate et al. · Clinical Cancer Research · 2008 · 277 citations

Medicine, Cancer Biology, Oncology +17

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

Shuo Wei, Shingo Kozono, Lev M. Kats et al. · Nature Medicine · 2015 · 268 citations · Full text

Life Sciences, Molecular Biology, Oncology +10

Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation

Ingvar Ferby, Markus Reschke, Oliver Kudlacek et al. · Nature Medicine · 2006 · 265 citations

Life Sciences, Cell Biology, Developmental Biology +17

1–5 of 25